MMP2, 8, 9 and TIMP1-4 levels in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease and bronchial asthma Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010
Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
Relationship between MMP-9 and TIMP-1 induced sputum concentration and the stage of chronic obstructive pulmonary disease‘s (COPD) Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008
Angiopoietins in sputum supernatant of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Blood cytokine expression in patients with chronic obstructive airway diseases (COAD) Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers and healthy controls Source: Eur Respir J 2001; 18: Suppl. 33, 520s Year: 2001
Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Micro-RNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Genetics of obstruction Year: 2010
The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010
Decreased release of TIMP-1 and TGF-β in cultured alveolar macrophages of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 222s Year: 2003
Decreased FOXP3 expression in small airways of smokers with COPD Source: Eur Respir J 2009; 33: 61-67 Year: 2009
Airway T-lymphocytes expressing IFN-γ are reduced in smokers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 6s Year: 2002
Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001